1-2 of 2
Ralph Parchment
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-in-Human Phase 1a Clinical Trial of the Investigational New Drug ST-001, a Novel Nano-Phospholipid Dispersion Formulation of Fenretinide, in Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma

Ali Moiin, Yamini Donekal, Louis Scarmoutzos, Michael Burns, Robert Patterson, Earle Holsapple, III, Ajay K. Gopal, Ralph Parchment, Oleg Akilov
Journal: Blood
Blood (2024) 144 (Supplement 1): 4453.1.
https://doi.org/10.1182/blood-2024-211734
Published: 2024
Journal Articles

A Phase 1a/1b Trial of ST-001, a Fenretinide Phospholipid Suspension for 4-Hour Intravenous Infusion in Relapsed/Refractory T-Cell Non-Hodgkin's Lymphoma

Ayad Al-Katib, MD, Timothy M. Kuzel, MD, Ralph Parchment, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4041.
https://doi.org/10.1182/blood-2019-127278
Published: 2019